Invokana clinical trial shows drug doubles risk of amputation

June 22, 2017 - Jansen reported Invokana reduced the risk of cardiovascular complications in diabetic patients, but it also doubled the number of amputations for patients taking Invokana compared to the... Read More

First retrievable IVC filters trial set for October

June 15, 2017 - Unlike permanent IVC filters, those of the retrievable variety have a high rate of failure. They are more fragile in design, often leading them to fracture, migrate or tilt within the body... Read More

Talcum powder ovarian cancer trial begins in St. Louis

June 7, 2017 - The sixth talc trial against Johnson & Johnson in City of St. Louis Circuit Court started this week. Plaintiffs represent the estates of three women who died from ovarian cancer following... Read More

First bellwether trial in testosterone litigation underway in Chicago

June 6, 2017 - The first trial in multidistrict litigation (MDL) involving testosterone replacement therapy (TRT) began June 5 in the U.S. District Court for Northern Illiniois in Chicago. Read More

High-viscosity bone cement may sacrifice surgical benefits

June 1, 2017 - A person usually opts for a total knee replacement (TKR) to regain their quality of life. Read More

Second Xarelto bellwether trial underway

May 25, 2017 - The second bellwether trial involving bleeding risks with the blood thinner Xarelto is slated to begin Tuesday following the Memorial Day holiday. Read More

Zofran maker GlaxoSmithKline still on hook for fraud claims

May 18, 2017 - GlaxoSmithKline (GSK) will not be allowed to sidestep its accountability for failing to warn pregnant women and their doctors about the dangers of Zofran when used to treat morning sickness. Read More

St. Louis jury returns $110 million verdict in trial linking Baby Powder to ovarian cancer

May 15, 2017 - A jury has awarded more than $110 million to a Virginia woman who claimed that decades of daily use of Johnson & Johnson’s (NYSE: JNJ) talcum powder products caused her ovarian cancer.... Read More

Critical documents expose talc link to ovarian cancer

May 9, 2017 - During their investigation of talc cases, Plaintiffs’ lawyers uncovered a decades-long cover-up by Johnson & Johnson and Imerys of the increased risk of ovarian cancer linked to its... Read More

First MDL trial over testosterone replacement drugs set for June

May 5, 2017 - Thousands of men have suffered negative and even life-threatening side effects after taking testosterone replacement drugs and they will soon have their day in court to question the... Read More

back to top